QUVIVIQ
Idorsia Pharmaceuticals Ltd.
Application Filed: 2019-11-05
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79274313 |
| Registration Number | 6166353 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2019-11-05 | Application Filed |
| 2019-12-19 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2019-12-19 | Status: Live/Pending |
| 2019-12-27 | Transaction Date |
| 2020-10-06 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Idorsia Pharmaceuticals Ltd. |
| Address | Hegenheimermattweg 91 CH-4123 Allschwil CH |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for human beings |
| GS0051 | Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-12-19 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-12-20 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2019-12-24 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-02-08 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-02-08 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-02-09 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-03-03 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-03-04 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-03-21 | 9 RFNT P: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-05-22 | 10 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-05-22 | 11 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-05-22 | 12 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-05-22 | 13 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-05-22 | 14 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-05-22 | 15 CHAN I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-22 | 16 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-22 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-23 | 18 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2020-06-12 | 19 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-06-12 | 20 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-06-12 | 21 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-06-12 | 22 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-06-12 | 23 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2020-06-15 | 24 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-07-01 | 25 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-07-15 | 26 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-07-15 | 27 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2020-07-21 | 28 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-21 | 29 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2020-07-31 | 30 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2020-10-06 | 31 R.PR A:Allowance for Publication |
| NEW REPRESENTATIVE AT IB RECEIVED | 2020-12-11 | 32 NREP P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-01-06 | 33 FICR P: |
| FINAL DISPOSITION PROCESSED | 2021-01-23 | 34 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2021-01-23 | 35 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-02-14 | 36 FINO P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 QUVIVIQ 79350361 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd 2022-07-06 |
 QUVIVIQ 79299719 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd 2020-10-08 |
 QUVIVIQ 79274313 not registered Live/Pending |
Idorsia Pharmaceuticals Ltd. 2019-11-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 